相关实验视频
Updated: Jan 17, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.0K
通过乙化激活T细胞内在的p53,引起抗瘤免疫力,以促进癌症免疫疗法
Xiaojun Yan1, Wenbin Xu1, Han Yao1
1State Key Laboratory of Common Mechanism Research for Major Diseases & Department of Medical Genetics, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Cancer discovery
|September 19, 2025
概括
在T细胞内在的p53乙化激活IFN-γ通路,在免疫治疗期间增强CD8+T细胞透和抗瘤免疫力. 这种模仿乙化的p53增强了免疫反应,揭示了p53在癌症治疗中的非瘤细胞自主作用.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 对于抗瘤免疫,T细胞内在的p53调节至关重要,但人们对其了解甚少.
- 在免疫治疗期间,p53在T细胞中的作用需要进一步阐明.
研究的目的:
- 在免疫治疗期间研究T细胞内在p53激活的机制.
- 为了确定p53碳素终端域 (CTD) 乙化对T细胞功能和抗瘤免疫力的影响.
- 探索p53和IFN-γ通路在T细胞介导的癌症防御中的关系.
主要方法:
- 利用T细胞特异性诺基因小鼠模型研究p53 CTD乙化.
- 评估 CD8+ T 细胞透和功能,以应对免疫疗法.
- 确定了T细胞内在p53的直接点,包括IFNG.
主要成果:
- 通过CTD乙化激活T细胞内在的p53,增强IFN-γ通路和CD8+T细胞透.
- 在T细胞中CTD乙化损失取消了抗瘤免疫力,而乙化模仿p53则增强了它.
- 建立了p53和IFN-γ之间的积极反循环,促进了T细胞依赖的抗瘤免疫力.
结论:
- 通过CTD乙化介导的T细胞内在p53的激活是免疫疗法疗效的关键驱动因素.
- T细胞内在的p53通过非瘤细胞自主机制促进抗瘤免疫力.
- 这项研究强调了p53在调节采用性免疫反应中的作用,以促进癌症免疫疗法.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
T Cell Activation and Clonal Selection
14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K

